Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can your blood pressure cuff spot a hidden heart problem?

NCT ID NCT04464499

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a smart blood pressure cuff called the Withings BPM Core can accurately detect atrial fibrillation, a common heart rhythm problem. Researchers will compare the device's single-lead ECG readings to a standard 12-lead ECG in 160 adults. If it works well, it could offer a convenient way for people to screen for AFib at home.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Withings BPM Core (smart blood pressure cuff with ECG)
What this could lead to
If successful, this device could help people easily check for atrial fibrillation at home, leading to earlier detection and treatment.
What could go wrong
This is a validation study, not a treatment trial. The device may not be as accurate as a standard ECG, and results may not apply to all users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2020

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

in and out patients from cardiology services

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * male or female who are 18 years or older * Subject who signed the written informed consent form, * Able to communicate effectively with and follow instructions from the study staff * Person with an arm circumference between 22 and 42 cm Exclusion Criteria: * Vulnerable subject with regard to regulations * Pregnant, parturient or breastfeeding woman, * Subject who is deprived of liberty by judicial, medical or administrative decision, * Underage subject, * Legally protected subject, or subject who is unable to sign the written informed consent form, * Subject who is not beneficiary or not affiliated to a social security scheme, * Subject within several of the above categories, * Subject who refused to participate in the study, * Subject in linguistic or psychic incapacity to sign a written informed consent form, * Subject in physical incapacity to wear a blood pressure monitor * Subject with electrical stimulation by pacemaker * Significant tremor that prevents subject from being able to hold still * Known sensitivity to medical adhesives, isopropyl alcohol, or ECG electrodes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arrhythmias, cardiac are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ICPC Floréale

    Bagnolet, 93170, France

  • ICPC Turin

    Paris, 75004, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.